Table 9. Pyrimidine Derivatives as LRRK2 Inhibitors.
IC50 |
|||||||
---|---|---|---|---|---|---|---|
no. | name | wild-type LRRK2 | LRRK2-G2019S | substrate | selectivitya | in vivo | lit. |
19 | CZC-25146 | 4.76 nMb | 6.87 nMb | LRRKtide | LRRKtide | male CD-1 mice | (71) |
20 | CZC-54252 | 1.28 nMb | 1.85 nMb | LRRKtide | LRRKtide | male CD-1 mice | (71) |
21 | LRRK2-IN-1 | 13 nMc | 6 nMc | Nictide | Nictide | Male C57BL/6 mice | (70) |
Number of all kinases, including LRRK2.
Human LRRK2 (wt/G2019S).
GST-LRRK2 (1326–2527; wt/G2019S).